Clinical Trials Browser

Phase 1 × Neoplasms × anlotinib × Clear all

NCT02752516 2017-09-18

A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics

Phase 1 Unknown

Neoplasms